Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants

Elizabeth G. Rhee, Matthew L. Rizk, Nicole Calder, Marcela Nefliu, Steven J. Warrington, Michael S. Schwartz, Eric Mangin, Keith Boundy, Pratik Bhagunde, Francheska Colon-Gonzalez, Patricia Jumes, Yang Liu, Joan R. Butterton
  • Antimicrobial Agents and Chemotherapy, June 2018, ASM Journals
  • DOI: 10.1128/aac.00280-18

The authors haven't yet claimed this publication.

Read Publication

In partnership with: